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ReviewSince the first isolation of dengue virus (DENV) in 1943,
four types have been identified. Global phenomena such
as urbanization and international travel are key factors in
facilitating the spread of dengue. Documenting the type-
specific record of DENV spread has important implica-
tions for understanding patterns in dengue hyperende-
micity and disease severity as well as vaccine design and
deployment strategies. Existing studies have examined
the spread of DENV types at regional or local scales, or
described phylogeographic relationships within a single
type. Here we summarize the global distribution of con-
firmed instances of each DENV type from 1943 to 2013 in a
series of global maps. These show the worldwide expan-
sion of the types, the expansion of disease hyperendemi-
city, and the establishment of an increasingly important
infectious disease of global public health significance.
Early spread and typing of DENV
DENV are members of the Flavivirus genus (see Glossary),
related to other medically important arboviruses such as
yellow fever and Japanese encephalitis viruses. There are
four phylogenetically and antigenically distinct dengue
viruses (DENV1–4), and although infection with one type
confers long-term immunity, it is to that type only and not
to the other three [1]. The ancestor of these viruses has
been postulated to have emerged about 1 000 years ago in
an infectious cycle involving non-human primates and
mosquitoes, with transmission to humans having occurred
independently for all four virus types only a few hundred
years ago [2,3]. Although outbreaks of disease clinically
consistent with dengue have been reported for centuries, it
was not until 1943 in Japan and 1945 in Hawaii that the
first two dengue viruses were isolated (named DENV1 and0966-842X   
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Open access under CC BY license.DENV2, respectively) [4]. At this point, epidemics of den-
gue illness were being reported across the region spanning
from India to the Pacific Islands. In the latter half of the
20th century, DENV transmission followed the spread of
its principal mosquito vector, Aedes aegypti [5], and was
likely accelerated by urbanization and globalization [6,7].
The collapse of the Ae. aegypti eradication campaign in the
Americas in the 1970s was also important in marking the
beginning of transport of Asian dengue viruses to the
Americas, followed by the rapid re-introduction of the
principal mosquito vector throughout both continents [8].
A need for type-specific global maps
Spatial patterns in concurrent and/or sequential circula-
tion of DENV1–4 should be considered along with virus
and host genetics as potentially important population-level
risk factors for severe dengue illness [9,10] because sec-
ondary infection with a heterologous DENV type may
increase the probability of severe disease [11–14]. Despite
this, no study has systematically reviewed all documented
spatially explicit evidence of the global spread of the four
DENV types since the first isolation in 1943. Rather, the
majority of existing studies have focused on the evolution
of individual DENV types at regional or local scales [15–
20]. Global descriptions of type-specific DENV distribution
are few in number, lacking spatial and temporal precision,
and are presented in a non-systematic manner [8].
Reported cases do not comprise the entire range of each
DENV type at any given time, meaning that a lack of
reporting for a specific type at any time or place does
not indicate its certain absence. This is due to spatialGlossary
Flavivirus: a family of single-stranded RNA viruses transmitted primarily by
ticks and mosquitoes.
Medical Subject Headings (MeSH) terminology: a wide-ranging and regulated
vocabulary for the purpose of indexing and searching for journal articles and
books in the life sciences; created by the US National Library of Medicine.
Sylvatic: denoting certain diseases contracted by and affecting wild animals,
and the pathogens causing them.
Review Trends in Microbiology March 2014, Vol. 22, No. 3variability in several factors, namely in the degree of
sampling, proportion of infections having been typed, relia-
bility of typing methods, and finally reporting of these
types. That said, the use of more advanced typing methods
has expanded significantly across the globe since their
development, and a thorough description of confirmed
presences of each DENV type is needed if we are to gain
a better understanding of the global dispersal of the four
viruses and track changes moving forward. Here we pro-
vide this baseline depiction, also highlighting those geo-
graphic areas lacking in information about the specific
DENV type(s) responsible for dengue occurrence.
Brady et al. [21] recently outlined the definitive extents
of dengue presence globally, and their work was followed
by that of Bhatt et al. [22] which generated high spatial-
resolution (5 km  5 km) estimates of contemporary global
dengue risk and burden in 2010. Our efforts here provide
further insight into the global distribution of dengue by
reviewing the individual DENV types responsible for
reported occurrence throughout the past seven decades.
Our aim is to complement phylogenetic and disease occur-
rence analyses by presenting the sub-national distribution
of reported confirmed instances of human infection with
each DENV type globally from 1943 to 2013. We provide a
more spatially and temporally detailed picture of the
spread of each individual DENV type than was previously
available, also presenting contemporary maps of the num-
ber of DENV types ever reported in an area to elucidate
global patterns in their co-circulation and establishment of
hyperendemicity.
Compiling a global database of DENV type reporting
We compiled an extensive database by extracting DENV
type and locational information from published literature
and case reports spanning the period 1943–2013. In brief,
searches were conducted in PubMed (http://www.ncbi.nlm/
pubmed) using the terms ‘dengue’ and ‘serotype’ or ‘type,’
and all pseudonyms were automatically included using the
Medical Subject Headings (MeSH) terminology. No lan-
guage restrictions were placed on these searches; however,
only those citations with a full title and abstract were
retrieved. In-house language skills allowed processing of
all English, French, Portuguese, and Spanish articles. We
were unable to extract information from a small number of
Turkish, Polish, Hebrew, Italian, German, and Chinese
articles. ProMED reports (http://www.promedmail.org)
were also searched using the terms ‘dengue’ and ‘serotype’
or ‘type’, and all DENV type data that could be linked to a
location were extracted, resulting in a search of 1 912
unique articles or reports. DENV type data from national
Ministry of Health websites were included where avail-
able, resulting in 294 additional sources of information.
Finally, DENV envelope protein gene sequences were
extracted from GenBank (http://www.ncbi.nlm.nih.gov/
genbank), providing another 1 070 sources for a total of
3 276 sources from which type and geographical coordinate
information was ultimately extracted. References for these
sources are available upon request.
Geo-positioning was performed to the finest level of
detail possible (e.g., country, province, district, or city/
town). In the case of a returning traveler report, werecorded the location visited as the site of the occurrence.
The database was last updated on 4 October 2013.
The sources we used to create our initial database often
described the occurrence of more than one DENV type at a
time and/or spanned multiple years. Conversely, it was
often the case that multiple sources were referring to the
same outbreak. To account for these concerns we derived a
standard definition of an occurrence as the following: one or
more reports of confirmed infection(s) from a specific
DENV type in a given unique location within a single year.
Accordingly, if multiple reports confirmed the presence of a
DENV type in the same location within the same calendar
year, they were considered as a single occurrence record. It
is thus important to stress that our definition of a type-
specific occurrence does not relate to the actual number of
cases reported (this information was not consistently avail-
able), but rather to the presence of that DENV type in a
given area and year.
For mapping and descriptive purposes, province- or
state-level administrative units (Admin1) served as our
unique locations. When information was only available at
the country (Admin0) level in a particular year, it was
included in the database for those countries smaller in area
than Queensland, Australia (the largest Admin1 unit in
our database at 1.7 million km2). From this final Admin1-
level occurrence database, a series of global maps were
created for each DENV type across six time-periods
between 1943 and 2013. We also present the number of
DENV types ever reported in a given area across these
time-periods. Graphs displaying yearly occurrences by
world region and country were also created (Figures S1–
S12 in the supplementary material online).
Although reports of suspected cases were excluded from
the database, no restrictions were made regarding the
specific diagnostic typing method used to confirm the
DENV type(s) responsible for an occurrence because not
all sources specified this information. This was particularly
true for ProMED reports that often simply reported cases
as confirmed without specifying the method of confirma-
tion; however, for comprehensiveness in our database, the
following identification method(s) were recorded: (i) virus
isolation, (ii) PCR, (iii) plaque-reduction neutralization
test (PRNT), (iv) not specified/other. The frequency of
occurrences confirmed by each of these methods is
described in Table S1 in the supplementary material
online. In some cases, immunoglobulin M (IgM), immuno-
globulin G (IgG), or hemagglutination inhibition (HI)
assays were used to confirm infection with DENV, but
used alone these methods are not useful for type-specific
DENV determination owing to DENV type cross-reactivity
[23]. As such, these were included in the not specified/other
category.
Mapping DENV spread
A total of 1 956 DENV1 occurrences, 1 931 DENV2 occur-
rences, 1 631 DENV3 occurrences, and 1 000 DENV4
occurrences were mapped at the Admin1 and small
Admin0 level across the entire study period. An additional
1 811 confirmed DENV occurrences were not attributable
to a specific type due to lack of testing and/or reporting.139
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Figure 1. Spatial distribution of reported confirmed cases of DENV1 since 1943. Darker-colored areas represent cases that were confirmed in the given decade under
consideration, whereas lighter-colored areas represent cases that had been previously reported but not in the current decade.
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type for the periods 1943–1959, 1960–1969, 1970–1979,
1980–1989, 1990–1999, and 2000–2013 as presented in
Figures 1–4.
These figures are complemented by additional graphs
(Figures S1–S12 in the supplementary material online)
that further break down the yearly distribution of occur-
rences for each DENV type by region (Africa, the Americas,
and Asia) and by country within those regions. To simplify
the number of categories presented in the supplementary
material online, the Americas were considered to include
North, Central, and South America, whereas Africa
includes the African continent as well as Yemen and Saudi
Arabia. The Asia region additionally includes Oceania and
the Pacific Islands. The supplementary material also con-
tains the summary of available information on type-spe-
cific diagnostic methods (Table S1 in the supplementary
material online). Again, this is provided for descriptive
purposes only because any occurrence described as con-
firmed was included in our database, regardless of diag-
nostic method, to obtain the most comprehensive picture of
DENV type distributions.
DENV1
Figure 1 displays the global spatial distribution of con-
firmed DENV1 occurrences by time period. DENV1 was
first reported in 1943 in French Polynesia and Japan,
followed by reports in Hawaii in 1944 and 1945. It was
not until the late 1950s, however, that reporting of DENV1
in the Asian region constantly increased over time. It was
first reported in Africa in 1984 in Sudan, and has been140sporadically reported in the region ever since, with more
continuous periods of reporting in Saudi Arabia between
the mid-1990s and mid-2000s, as well as several years of
reporting in Reunion in the mid-to-late 2000s. DENV1 was
not reported in the Americas until 1977, when it was
recorded in Barbados, Cuba, French Antilles, Grenada,
Paraguay, and Puerto Rico. After these first recorded
occurrences, reporting increased persistently across the
region over the next few decades, with near-continuous
reporting in Brazil, Mexico, and Puerto Rico in particular.
Several other countries in the region began having more
sustained reports in the 1980s and 1990s, including Colom-
bia, Costa Rica, French Guiana, Paraguay, Peru, and
Venezuela. Reporting of DENV1 peaked in 2005–2006,
primarily attributable to recorded occurrences in the
Americas. Since 1983, the Pan American Health Organiza-
tion (PAHO), in collaboration with the US Centers for
Disease Control (CDC) Dengue Branch in Puerto Rico,
provided technical assistance for developing laboratory
surveillance networks in several countries in the region,
and this may partially explain increased reporting of all
DENV types since this time.
DENV2
DENV2 was first reported in 1944 in Papua New Guinea
and Indonesia, followed by the Philippines in 1954 and
1956. Malaysia and Thailand have reported many conse-
cutive years of DENV2 occurrence since the early 1960s, as
well as Indonesia since the early 1970s and China, India,
the Philippines, Sri Lanka, and Singapore since the 1980s.
Continuous reporting did not occur in Cambodia and
1943−1959
1960−1969
1970−1979
1990−1999
2000−2013
1980−1989
TRENDS in Microbiology 
Figure 2. Spatial distribution of reported confirmed cases of DENV2 since 1943. Darker-colored areas represent cases that were confirmed in the given decade under
consideration, whereas lighter-colored areas represent cases that had been previously reported but not in the current decade.
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Nigeria multiple times between 1964 and 1968, but has not
since been reported there. However, several sporadic
occurrences have since been reported in the African region,
with the most recent reports being from Gabon in 2010 and
Kenya in 2013. DENV2 was reported in the Americas as
early as 1953 in Trinidad and Tobago, but continuous
reporting in the region did not begin until the late 1960s
and early 1970s, most notably in Puerto Rico. Since this
time, more and more Latin American countries have begun
frequent reporting of DENV2, with continuous reporting in
Brazil in particular since 1984 accounting for the majority
of reporting of this type globally. In the 1990s, there was an
increase in the number of the more severe hemorrhagic
fever (DHF) cases in the Americas, possibly due to the
replacement of the American DENV2 genotype with an
imported and more virulent Asian one [24–27]. This
increase in DHF cases may be responsible for the notice-
able rise in DENV2 reporting in this region since that time,
as seen in Figure 2. The largest number of occurrences
reported to date was in 2005, with over 100 Admin1 and
small Admin0 areas worldwide reporting DENV2 pre-
sence, primarily in the Americas.
DENV3
DENV3 was first reported in 1953 in the Philippines and
Thailand, and has been reported in Asia every year since
1962. Although many countries in Asia have reported
DENV3 throughout the study period, Thailand most nota-
bly reported DENV3 every year between 1973 and 2010,
with the most widespread reporting occurring between1999 and 2002. Malaysia and Indonesia have also reported
DENV3 frequently since the 1970s, as well as Sri Lanka
since the early 1980s. Records of DENV3 in China, Viet-
nam, Cambodia, and Singapore have been fairly consistent
since the mid-1990s. The first reports in the Americas were
in Puerto Rico in 1963, which continued to report DENV3
until 1978, and then again from 1994 to 2008 owing to the
introduction of a new DENV3 genotype from Asia [28]. The
majority of other countries in the Americas did not start
reporting the type until between the late 1980s and early
2000s. Particularly widespread reporting occurred in Bra-
zil in the mid-2000s. In Africa, overall very little DENV3
has been reported since the first reports in 1984–1985 in
Mozambique, and occurrence has mostly been sporadic,
with the exception of more frequent reporting between
1994 and 2009 in Saudi Arabia.
DENV4
DENV4 was reported first in 1953 in the Philippines and
Thailand. Since this time the region has reported DENV4
yearly, most frequently in Thailand whose most wide-
spread reporting occurred between 1999 and 2002. Sri
Lanka has also reported DENV4 almost yearly since
1978. Although reporting by country has not been as
consistent as for other DENV types, periods of more fre-
quent reporting have occurred in the Indochina region as
well as Indonesia, India, Myanmar, and French Polynesia.
DENV4 was not reported in the Americas until 1981, when
it was reported in Brazil, Cuba, Dominica, Puerto Rico, and
the US Virgin Islands. Since this date, reporting has
occurred yearly in the region, with particularly frequent141
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Figure 3. Spatial distribution of reported confirmed cases of DENV3 since 1943. Darker-colored areas represent cases that were confirmed in the given decade under
consideration, whereas lighter-colored areas represent cases that had been previously reported but not in the current decade.
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Figure 4. Spatial distribution of reported confirmed cases of DENV4 since 1943. Darker-colored areas represent cases that were confirmed in the given decade under
consideration, whereas lighter-colored areas represent cases that had been previously reported but not in the current decade.
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Figure 5. DENV Co-circulation. Cumulative number of DENV types reported by decade since 1943.
Review Trends in Microbiology March 2014, Vol. 22, No. 3reporting in Puerto Rico since the 1980s–1990s, Venezuela
and Colombia since the 1990s, and Nicaragua, Brazil, and
Peru since the late 1990s–mid 2000s.
Co-circulation of DENV types
Figure 5 displays the cumulative number of DENV types
having been reported in any given Admin1 and small
Admin0 area by decade, and highlights the fact that, until
the 1980s, the majority of areas had only reported one or
two types of DENV. This figure allows the observation of
potential increases in co-circulation of the four viruses,
which may serve as a key indicator of progression toward
hyperendemic transmission [29]. In the late 1980s, the
number of types having been reported within a single area
began to increase as more cost-effective and less labor-
intensive type-specific diagnostic tests (e.g., PCR) were
developed for dengue [30]. This may also explain increases
in global reporting of specific DENV types at this time,
although the number of reported DENV types has since
continued to increase in many areas across Latin America
and the Caribbean islands, as well as in Southeast Asia,
the Indian subcontinent, Indonesia, and Australia. This is
particularly noticeable in the map representing 2000–
2013, by which time the majority of Brazilian provinces
as well as much of Mexico, India, and Indonesia had
reported every DENV type. Although few areas in Africa
have reported all four DENV types, by the 2000s several
areas had reported three. However, it is unclear whetherthese all represent the persistently transmitted epidemic
form of the virus, or are only sporadic overspills from the
sylvatic transmission cycle.
Exponential growth in DENV type reporting
Reporting of DENV type is irregular and affected by many
types of bias, in particular in locations with less virological
diagnostic capacity, and thus our database represents an
opportunistic sample of occurrence. As such, it is important
to remember that an absence of reporting for one DENV
type is not synonymous with an absence of its occurrence. It
is also important to remember that our definition of a type
occurrence does not relate to the actual number of cases
reported, but rather to the presence of the DENV type in a
given area and year. Furthermore, because our definition
of a type occurrence does not relate to the actual number of
cases reported, but rather the presence of the DENV type
in a given area and year, it is impossible to make inferences
about the relative prevalence of each type in any given
location. That said, the records that support this review
comprise the most comprehensive type-specific DENV
database to date, and its breadth allows a much more
detailed depiction of spread than was previously available.
Although there is general agreement that several fac-
tors have led to an expansion of the geographic range of
dengue over our study period, and particularly in the latter
half of the 20th century [6,31–36], the variability in report-
ing practices over time as well as by region and country143
Box 1. Outstanding questions
 How can we quantify the importance of travel, migration, and
commercial trade in the global spread and evolution of DENV
types?
 Does co-circulation of DENV types increase the incidence of more
severe disease outcomes in a given area? A greater number of
seroprevalence studies involving active surveillance are required
to answer this question.
 What is the distribution of DENV types in Africa? Although
returning traveler reports are useful for establishing the presence
of certain types in some African countries, these reports are
currently infrequent and sporadic. Greater surveillance efforts are
needed in Africa.
Review Trends in Microbiology March 2014, Vol. 22, No. 3must be considered alongside apparent patterns of expan-
sion [37]. Improvements in reporting capacity over time
will have had a significant effect on the number of cases
being reported, compounded by the fact that increasing co-
circulation of DENV types may be associated with more
severe disease outcomes which are therefore more likely to
be reported. However, this study makes it clear that den-
gue detection has increased dramatically across the globe
since 1943, with some DENV types being newly reported in
particular areas more rapidly than others. DENV1 was
reported to occur the most times during this 70 year study
period, followed by DENV2, DENV3, and DENV4. The
overall number of confirmed type-specific DENV events
particularly escalated in the 1990s, primarily comprising
increases in DENV1 and DENV2 detection in the Americas
owing to the availability of rapid diagnostic tests. In Asia,
although DENV2 reporting has increased rapidly, DENV3
reporting has surpassed that of DENV1. The greatest
increase in reporting of DENV3 occurred in the 1990s,
predominantly in the Americas. DENV4 reporting spread
the least rapidly during the 70 year period, although it has
been consistently reported in ever-greater numbers since
the 1980s, particularly in Asia and the Americas.
Although documenting dramatic increases in DENV
reporting across Asia and the Americas, our review also
underscores the fact that there still remains a dearth of
type-specific DENV information in many parts of Africa –
where our understanding of the evolutionary history and
current dynamic of DENV transmission and spread is also
poorest. Both research efforts and numbers of reports have
remained relatively low here compared to Asia and the
Americas, although several arboviral studies have been
conducted in the region since the 1980s [38–56]. This
problem is made worse by the lack of DENV type-specific
information in the few countries where occurrence reports
are available. This is particularly true in the countries of
east Africa where evidence for dengue presence is high [21],
but little information exists about the specific location(s)
within these countries where DENV has occurred or about
the DENV type(s) responsible for occurrence.
Research outlook
Additional research questions can be explored with use of
the database presented here, such as those surrounding
the importance of travel, migration, and commercial trade
in the spread of dengue, the introduction of novel DENV
types (and/or genotypes) into locations where DENV is or is
not already present [57], and DENV population structure
and evolution, as well as casting light on how human
immunity mediates DENV transmission at the micro
and macro scales (Box 1) [58]. The ability to answer these
questions will complement phylogenetic studies, and may
even be integrated with phylogeographic studies of DENV
evolution and dispersal on a regional and global scale [59–
61]. The comprehensive database that has been compiled
will be made publicly available (via http://figshare.com
[62]) such that it can be directly referred to in order to
facilitate DENV type identification in historic samples,
thereby providing information about what specific viruses
were circulating in an area at a particular time. Tracking
the spread of DENV types also has important implications144for ongoing research [15] analyzing changes in dengue
endemicity in a given area over time.
Continuing spread has global implications
Although international transmission of disease is not new,
it is notable that airline passenger numbers have increased
by 9% annually since 1960, enabling infected human hosts
to move the viruses long distances more quickly [27,63].
Increased urbanization along with substandard housing,
unreliable water supply, and poor sanitation provide an
environment for Ae. aegypti proliferation in close proximity
to human hosts. In the Americas, this may have been
exacerbated by the collapse of the Ae. aegypti eradication
program in the 1970s [8]. Increases in the size of resource-
poor urban populations in Latin America and the Carib-
bean in the late 1980s and early 1990s may have supported
the establishment and spread of all four DENV types in the
Americas [64]. According to the United Nations Population
Division, between 2000 and 2030, Africa and Asia together
are expected to account for four-fifths of all urban growth in
the world (see http://esa.un.org/unpd/wpp/Documentation/
pdf/WPP2012_Volume-I_Comprehensive-Tables.pdf).
Therefore, it is essential that we closely monitor the
ongoing and future spread of DENV types in these regions
to understand, detect, and respond better to the global
burden of dengue disease.
Finally, because our maps have underscored the ability
of all four DENV types to expand into new territories, the
crucial need for a DENV vaccine which protects against all
four known types is made ever more apparent [64]. It is
also important to note the recent suggestion of a fifth
DENV type [65] which, if found to be as transmissible as
the other four DENV types, might follow a similar pattern
of geographical spread as seen with these types over the
past two decades. If sustained transmission of a fifth type
did occur in human populations, this would be an addi-
tional consideration for vaccine development efforts
[64,66], and an up-to-date map of the spread of DENV
types would be essential.
Concluding remarks
In sum, this review offers the most contemporary under-
standing of DENV type-specific geographic distributions
from 1943 to 2013, providing a starting point and rationale
for charting the ongoing global spread of each DENV type.
Specifically, the increasing co-circulation of types in most
regions of the world – particularly in Latin America and
Review Trends in Microbiology March 2014, Vol. 22, No. 3Asia – has important implications for patterns in disease
severity and hyperendemicity, as well as for ongoing vac-
cine efforts. It also highlights a paucity of DENV type-
specific geographic information in many locations across
the globe that needs to be urgently addressed.
Appendix A. Supplementary data
Supplementary data associated with this article can be
found, in the online version, at http://dx.doi.org/10.1016/
j.tim.2013.12.011.
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